Response to Individualized vs. conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
Longobardi S, D'Hooghe T. Response to Individualized vs. conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertility And Sterility 2023, 121: 706. PMID: 38147958, DOI: 10.1016/j.fertnstert.2023.12.024.Peer-Reviewed Original ResearchHome Monitoring of Art Cycles
Zheng W, Gerris J, Dancet E, D'Hooghe T. Home Monitoring of Art Cycles. 2023, 539-546. DOI: 10.1201/9781003268611-49.Peer-Reviewed Original ResearchAssisted reproductive technologyControlled ovarian stimulationOvarian hyperstimulation syndromeHormone testClinic-based monitoringLoss of incomeHyperstimulation syndromeCycle monitoringOvarian responseOvarian stimulationSerum hormone assaysAssess ovarian responseReproductive technologyVaginal ultrasoundHealth approachHormone assaysPrevent complicationsBlood withdrawalTailored treatmentTele-counselingUltrasoundOffice hoursTreatmentIncomeEffectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years
Bielfeld A, Schwarze J, Verpillat P, Lispi M, Fischer R, Hayward B, Chuderland D, D'Hooghe T, Krussel J. Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years. Reproductive BioMedicine Online 2023, 48: 103725. PMID: 38593745, DOI: 10.1016/j.rbmo.2023.103725.Peer-Reviewed Original ResearchAdvanced maternal ageWomen of advanced maternal ageR-hLHR-hFSHRecombinant human FSHLive birthsClinical pregnancyOvarian stimulationHuman FSHPost hoc analysis of womenRecombinant human LHLive birth rateNormal ovarian reserveNon-interventional studyAssisted reproductive technologyAnalysis of womenPost hoc analysisOvarian reserveMaternal ageEffects of treatmentHuman LHAlone groupPatient groupClinical trialsART treatmentP-238 Non-interventional study comparing the effectiveness and safety of r-hFSH:r-hLH versus r-hFSH in women aged 35-42 years with normal ovarian reserve undergoing GnRH antagonist ART treatment
Arvis P, Lehert P, Chuderland D, Schwarze J, Helwig C, Bidet M, Guivarc'h Leveque A, Lispi M, D'Hooghe T. P-238 Non-interventional study comparing the effectiveness and safety of r-hFSH:r-hLH versus r-hFSH in women aged 35-42 years with normal ovarian reserve undergoing GnRH antagonist ART treatment. Human Reproduction 2023, 38 DOI: 10.1093/humrep/dead093.596.Peer-Reviewed Original ResearchNormal ovarian reserveR-hLHR-hFSHLive birth rateOvarian stimulationOvarian reserveNon-interventional studyART treatmentFrench centersLive birthsPregnancy rateOS cyclesClinical pregnancy rateAdvanced maternal ageOngoing pregnancy rateOvarian reserve biomarkersLow ovarian reserveAnalysis of clinical dataSubgroup of patientsFollow-up periodPregnancy failure rateBirth rateSecondary analysis of clinical dataClinical pregnancyAMH levels